Atsunori Yorozu
Papers
1
Total Citations
4
H-Index
1
About
Atsunori Yorozu is a leading figure in radiation oncology, with a focused expertise in the management of prostate cancer, particularly through brachytherapy. His major contributions center on refining salvage treatments for patients with locally recurrent prostate cancer following initial definitive radiotherapy. In a pivotal 2019 case series, Yorozu systematically compared outcomes between salvage iodine-125 brachytherapy and robot-assisted radical prostatectomy, providing critical evidence for treatment selection in this challenging clinical scenario. This work, which has garnered 4 citations, demonstrates his commitment to improving survival and reducing toxicity in recurrent disease. Beyond this, Yorozu has been instrumental in advancing whole-gland salvage strategies, offering new hope to patients with limited options. His research bridges the gap between surgical and radiation-based approaches, making him a key voice in multidisciplinary prostate cancer care. With a career dedicated to optimizing therapeutic outcomes, Yorozu’s contributions continue to shape clinical guidelines and inspire further investigation into personalized salvage therapies.
Research Focus
Key Achievements
Top Papers
- 1